Loading...
XNASMTEX
Market cap28mUSD
Jan 10, Last price  
14.98USD
1D
-1.19%
1Q
94.55%
Jan 2017
-26.21%
Name

Mannatech Inc

Chart & Performance

D1W1MN
XNAS:MTEX chart
P/E
—
P/S
0.21
EPS
—
Div Yield, %
2.65%
Shrs. gr., 5y
-5.99%
Rev. gr., 5y
-5.33%
Revenues
132m
-3.83%
294,508,000389,383,000410,069,000412,678,000332,703,000289,705,000228,088,000200,689,000173,447,000177,423,000190,081,000180,267,000180,304,000176,696,000173,558,000157,728,000151,407,000159,762,000137,208,000131,955,000
Net income
-2m
L-50.13%
19,552,00028,647,00032,390,0006,594,000-12,628,000-17,368,000-10,616,000-20,659,000-1,388,0003,174,0006,496,0005,839,000-586,000-1,787,000-3,886,0003,289,0006,261,0009,842,000-4,490,000-2,239,000
CFO
-2m
L-8.81%
29,860,00042,964,00039,912,00017,776,000-19,888,000-10,310,0003,995,000-2,874,000-1,192,0008,562,0009,420,0004,386,000-23,0009,998,000-222,0004,917,0006,030,00010,774,000-2,599,000-2,370,000
Dividend
Jun 14, 20230.2 USD/sh
Earnings
Mar 26, 2025

Profile

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
URL
https://us.mannatech.com/
IPO date
Feb 16, 1999
Employees
228
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
131,955
-3.83%
137,208
-14.12%
Cost of revenue
78,503
144,483
Unusual Expense (Income)
NOPBT
53,452
(7,275)
NOPBT Margin
40.51%
Operating Taxes
1,109
4,011
Tax Rate
2.07%
NOPAT
52,343
(11,286)
Net income
(2,239)
-50.13%
(4,490)
-145.62%
Dividends
(748)
(1,532)
Dividend yield
4.95%
4.47%
Proceeds from repurchase of equity
(176)
817
BB yield
1.16%
-2.39%
Debt
Debt current
2,170
324
Long-term debt
9,042
237
Deferred revenue
Other long-term liabilities
1,386
5,026
Net debt
2,763
(13,692)
Cash flow
Cash from operating activities
(2,370)
(2,599)
CAPEX
(748)
(1,063)
Cash from investing activities
(747)
(1,063)
Cash from financing activities
(1,903)
(4,331)
FCF
48,640
(10,806)
Balance
Cash
7,731
13,777
Long term investments
718
476
Excess cash
1,851
7,393
Stockholders' equity
(2,316)
1,478
Invested Capital
19,912
14,855
ROIC
301.11%
ROCE
303.77%
EV
Common stock shares outstanding
1,866
1,913
Price
8.10
-54.75%
17.90
-53.29%
Market cap
15,115
-55.86%
34,243
-57.20%
EV
17,878
20,551
EBITDA
55,080
(5,648)
EV/EBITDA
0.32
Interest
88
Interest/NOPBT